Published in J Clin Endocrinol Metab on April 01, 1973
Hidden from view: violent deaths among pregnant women in the District of Columbia, 1988-1996. J Midwifery Womens Health (2001) 2.95
Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med (1991) 2.93
Pituitary and gonadal hormones in women during spontaneous and induced ovulatory cycles. Recent Prog Horm Res (1970) 1.82
Studies on Leydig cell physiology and pathology: secretion and metabolism of testosterone. Recent Prog Horm Res (1966) 1.74
Cortisol production rate in childhood and adolescence. J Pediatr (1990) 1.66
The incidental adrenal mass. Am J Med (1996) 1.65
Enzymatic radioiodination of gonadotropins. J Clin Endocrinol Metab (1972) 1.61
Resistance to several steroids in two sisters. J Clin Endocrinol Metab (1999) 1.57
Methods for Labeling Thyroxine With Radioactive Iodine. Science (1948) 1.54
Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. N Engl J Med (1987) 1.50
Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries. J Clin Invest (1967) 1.47
Short message service reminder intervention doubles sexually transmitted infection/HIV re-testing rates among men who have sex with men. Sex Transm Infect (2011) 1.47
Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N Engl J Med (1986) 1.45
Allergy to purified bovine, porcine, and human insulins. Br Med J (Clin Res Ed) (1983) 1.44
Alternate-day prednisone therapy. Evaluation of delayed hypersensitivity responses, control of disease and steroid side effects. N Engl J Med (1969) 1.42
Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab (1991) 1.40
True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog. J Clin Endocrinol Metab (1984) 1.40
Cimetidine is an antiandrogen in the rat. Gastroenterology (1979) 1.40
Studies of the pituitary-Leydig cell axis in young men with hypogonadotropic hypogonadism and hyposmia: comparison with normal men, prepuberal boys, and hypopituitary patients. J Clin Invest (1969) 1.38
The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. N Engl J Med (1984) 1.36
Special report. Steriod receptors in breast cancer. N Engl J Med (1979) 1.33
Hypothalamic dysfunction in patients with anorexia nervosa. Medicine (Baltimore) (1974) 1.31
Corpus luteum function in early pregnancy. J Clin Endocrinol Metab (1969) 1.30
Plasma progesterone and 17-hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia. J Clin Invest (1969) 1.29
Comparison of the effect of the pyrogens, etiocholanolone and bacterial endotoxin on plasma cortisol and growth hormone in man. J Clin Endocrinol Metab (1968) 1.21
Estrone sulfate: production rate and metabolism in man. J Clin Invest (1972) 1.20
Effect of advertising on awareness of symptoms of diabetes among the general public: the British Diabetic Association Study. BMJ (1994) 1.20
Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress. J Clin Endocrinol Metab (1987) 1.19
Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease. J Clin Invest (1982) 1.18
Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone. J Clin Endocrinol Metab (1988) 1.18
The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy. J Pediatr (1986) 1.18
Is azithromycin adequate treatment for asymptomatic rectal chlamydia? Int J STD AIDS (2011) 1.17
Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab (1981) 1.17
Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report. N Engl J Med (1981) 1.16
Mechanisms of corticosteroid action on lymphocyte subpopulations. VI. Lack of correlation between glucocorticosteroid receptors and the differential effects of glucocorticosteroids on T-cell subpopulations. Cell Immunol (1980) 1.16
A preliminary study of the effect of estrogen dose on growth in Turner's syndrome. N Engl J Med (1983) 1.16
Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab (1985) 1.14
Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients. N Engl J Med (1986) 1.13
The measurement of estrone sulfate in plasma. Steroids (1971) 1.13
Adrenarche: a survey of rodents, domestic animals, and primates. Endocrinology (1978) 1.13
Site of action of clomiphene citrate in men: a study of the pituitary-Leydig cell axis. J Clin Endocrinol Metab (1967) 1.12
Pregnancies after chemotherapy of trophoblastic neoplasms. Science (1970) 1.12
Effects of induced hyperthyroidism on steroid metabolism in man. J Clin Endocrinol Metab (1971) 1.12
Localization and molecular modelling of the membrane-inserted domain of the ninth component of human complement and perforin. Mol Immunol (1990) 1.11
Increase in invasive Streptococcus pyogenes and Streptococcus pneumoniae infections in England, December 2010 to January 2011. Euro Surveill (2011) 1.11
Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist. J Steroid Biochem (1988) 1.09
Humoral syndromes associated with cancer. Cancer Res (1965) 1.09
Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem. Ann Surg (1994) 1.08
Trends in sources of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia: data from the national mandatory surveillance of MRSA bacteraemia in England, 2006-2009. J Hosp Infect (2011) 1.08
Diabetes mellitus and optic atrophy with associated findings of diabetes insipidus and neurosensory hearing loss in two siblings. Arch Intern Med (1974) 1.06
Diagnostic problems of choriocarcinoma and related trophoblastic neoplasms. Obstet Gynecol (1967) 1.06
Hormones, emotional dispositions, and aggressive attributes in young adolescents. Child Dev (1987) 1.06
Glucocorticoid hormone resistance during primate evolution: receptor-mediated mechanisms. Proc Natl Acad Sci U S A (1982) 1.06
Usefulness of inferior petrosal sinus venous endocrine markers in Cushing's disease. J Neurosurg (1988) 1.06
The collagen binding domain of fibronectin contains a high affinity binding site for Candida albicans. J Biol Chem (1994) 1.05
Cerebellar involvement in multifocal eosinophilic granuloma: demonstration by computerized tomographic scanning. Ann Neurol (1980) 1.05
The short luteal phase. J Clin Endocrinol Metab (1970) 1.05
The polyendocrine deficiency syndromes. N Engl J Med (1985) 1.04
A radioimmunoassay for cortisol in plasma and urine. J Clin Endocrinol Metab (1972) 1.04
A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab (1993) 1.04
A radioimmunoassay for plasma corticosterone. Steroids (1972) 1.03
Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging. Radiology (1989) 1.02
Ocular findings in Turner syndrome. A prospective study. Ophthalmology (1984) 1.02
Growth hormone secretory dynamics in Turner syndrome. J Pediatr (1985) 1.02
Studies on the mechanism of benzene toxicity. Environ Health Perspect (1989) 1.02
Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N Engl J Med (1985) 1.02
Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J Cell Biochem (1994) 1.01
Repeat transsphenoidal surgery for Cushing's disease. J Neurosurg (1989) 1.01
Treatment of familial male precocious puberty with spironolactone and testolactone. N Engl J Med (1989) 1.01
Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am J Psychiatry (1984) 1.00
Measurement of 17-hydroxyprogesterone in human plasma. J Clin Endocrinol Metab (1968) 1.00
On the nature and ethics of phase I clinical trials of cancer chemotherapies. JAMA (1982) 1.00
The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome. Ann Intern Med (1986) 0.99
Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion. J Clin Endocrinol Metab (1984) 0.98
Petrosal sinus sampling for Cushing syndrome: anatomical and technical considerations. Work in progress. Radiology (1984) 0.98
The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome. J Clin Endocrinol Metab (1987) 0.97
A dispersed-whole cell method for the determination of androgen receptors in human skin fibroblasts. Steroids (1980) 0.96
The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man. J Endocrinol (1973) 0.96
Effect of pyrogen on blood levels of pituitary trophic hormones. Observations of the usefulness of the growth hormone response in the detection of pituitary disease. J Clin Endocrinol Metab (1967) 0.96
Vertebral body bone mineral content in hyperprolactinemic women. J Clin Endocrinol Metab (1984) 0.95
Late-onset 21-hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease. Ann Intern Med (1982) 0.95
Primary pigmented nodular adrenocortical disease. A light and electron microscopic study of eight cases. Am J Surg Pathol (1989) 0.95
New evidence for an anti-estrogenic action of clomiphene citrate in women. J Clin Endocrinol Metab (1971) 0.95
Effect of low doses of estradiol on 6-month growth rates and predicted height in patients with Turner syndrome. J Pediatr (1986) 0.94
The metabolic clearance rate and origin of plasma dihydrotestosterone in man and its conversion to the 5-alpha-androstanediols. J Clin Invest (1971) 0.94
Studies on the transfer of steroid hormones across the blood-cerebrospinal fluid barrier in the Rhesus Monkey. Endocrinology (1976) 0.94
Ovarian physiology: relationship between plasma LH and steroidogenesis by the follicle and corpus luteum; effect of HCG. J Clin Endocrinol Metab (1969) 0.94
Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. N Engl J Med (1986) 0.94
Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging. Radiology (1987) 0.93
Barriers to the delivery of the hepatitis B birth dose: a study of five Papua New Guinean hospitals in 2007. P N G Med J (2009) 0.93
The relation of relative hormonal levels and physical development and social-emotional behavior in young adolescents. J Youth Adolesc (1985) 0.93
Chemotherapy in women with trophoblastic disease: choriocarcinoma, chorioadenoma destruens, and complicated hydatidiform mole. Ann N Y Acad Sci (1964) 0.93
Structure and function of rat testis through pubescence. Endocrinology (1970) 0.93